The neuropeptide galanin is a novel inhibitor of human hair growth

B. S. Holub, J. E. Kloepper, B. I. Tó Th, T. Bíro, Barbara Kofler, Ralf Paus

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Galanin is a trophic factor of the central and peripheral nervous system that shows widespread distribution in human skin. However, the exact localization and the role of galanin in the hair follicle (HF) remain to be clarified. Objectives: To characterize galanin expression in human scalp HFs and to examine the effects of galanin on normal human scalp HF growth in organ culture. Methods: Immunohistochemistry was performed on cryosections of human female scalp skin. Anagen HFs were microdissected and cultured up to 9 days and treated with 100 nmol L -1 galanin. Staining for Ki-67, TUNEL and Masson-Fontana were used to analyse proliferation, apoptosis and hair cycle staging of the HFs. Functional effects of galanin were tested in serum-free HF organ culture. Results: Galanin-like immunoreactivity was detected in the outer root sheath (ORS) and inner root sheath. Additionally, galanin mRNA was detected in ORS keratinocytes and all HF samples tested. Galanin receptor transcripts (GalR2, GalR3) were also detected in selected samples. Galanin reduced proliferation of hair matrix keratinocytes in situ compared with vehicle-treated controls, shortened the hair growth phase (anagen) in vitro and reduced hair shaft elongation. This was accompanied by the premature development of a catagen-like morphology of galanin-treated HFs. Conclusions: We present the first evidence that human HFs are both a source and a functionally relevant target of galanin. Due to its hair growth-inhibitory properties in vitro, galanin application deserves further exploration as a potential new treatment strategy for unwanted hair growth (hirsutism, hypertrichosis).

Original languageEnglish (US)
Pages (from-to)10-16
Number of pages7
JournalBritish Journal of Dermatology
Volume167
Issue number1
DOIs
StatePublished - Jul 1 2012
Externally publishedYes

Fingerprint

Galanin
Neuropeptides
Hair
Growth
Hair Follicle
Scalp
Organ Culture Techniques
Keratinocytes
Galanin Receptors
Hypertrichosis
Hirsutism
Skin
In Situ Nick-End Labeling
Peripheral Nervous System

ASJC Scopus subject areas

  • Dermatology

Cite this

The neuropeptide galanin is a novel inhibitor of human hair growth. / Holub, B. S.; Kloepper, J. E.; Tó Th, B. I.; Bíro, T.; Kofler, Barbara; Paus, Ralf.

In: British Journal of Dermatology, Vol. 167, No. 1, 01.07.2012, p. 10-16.

Research output: Contribution to journalArticle

Holub, B. S. ; Kloepper, J. E. ; Tó Th, B. I. ; Bíro, T. ; Kofler, Barbara ; Paus, Ralf. / The neuropeptide galanin is a novel inhibitor of human hair growth. In: British Journal of Dermatology. 2012 ; Vol. 167, No. 1. pp. 10-16.
@article{64ad9f1b0eee4cebb56d0b5e705264a6,
title = "The neuropeptide galanin is a novel inhibitor of human hair growth",
abstract = "Background: Galanin is a trophic factor of the central and peripheral nervous system that shows widespread distribution in human skin. However, the exact localization and the role of galanin in the hair follicle (HF) remain to be clarified. Objectives: To characterize galanin expression in human scalp HFs and to examine the effects of galanin on normal human scalp HF growth in organ culture. Methods: Immunohistochemistry was performed on cryosections of human female scalp skin. Anagen HFs were microdissected and cultured up to 9 days and treated with 100 nmol L -1 galanin. Staining for Ki-67, TUNEL and Masson-Fontana were used to analyse proliferation, apoptosis and hair cycle staging of the HFs. Functional effects of galanin were tested in serum-free HF organ culture. Results: Galanin-like immunoreactivity was detected in the outer root sheath (ORS) and inner root sheath. Additionally, galanin mRNA was detected in ORS keratinocytes and all HF samples tested. Galanin receptor transcripts (GalR2, GalR3) were also detected in selected samples. Galanin reduced proliferation of hair matrix keratinocytes in situ compared with vehicle-treated controls, shortened the hair growth phase (anagen) in vitro and reduced hair shaft elongation. This was accompanied by the premature development of a catagen-like morphology of galanin-treated HFs. Conclusions: We present the first evidence that human HFs are both a source and a functionally relevant target of galanin. Due to its hair growth-inhibitory properties in vitro, galanin application deserves further exploration as a potential new treatment strategy for unwanted hair growth (hirsutism, hypertrichosis).",
author = "Holub, {B. S.} and Kloepper, {J. E.} and {T{\'o} Th}, {B. I.} and T. B{\'i}ro and Barbara Kofler and Ralf Paus",
year = "2012",
month = "7",
day = "1",
doi = "10.1111/j.1365-2133.2012.10890.x",
language = "English (US)",
volume = "167",
pages = "10--16",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - The neuropeptide galanin is a novel inhibitor of human hair growth

AU - Holub, B. S.

AU - Kloepper, J. E.

AU - Tó Th, B. I.

AU - Bíro, T.

AU - Kofler, Barbara

AU - Paus, Ralf

PY - 2012/7/1

Y1 - 2012/7/1

N2 - Background: Galanin is a trophic factor of the central and peripheral nervous system that shows widespread distribution in human skin. However, the exact localization and the role of galanin in the hair follicle (HF) remain to be clarified. Objectives: To characterize galanin expression in human scalp HFs and to examine the effects of galanin on normal human scalp HF growth in organ culture. Methods: Immunohistochemistry was performed on cryosections of human female scalp skin. Anagen HFs were microdissected and cultured up to 9 days and treated with 100 nmol L -1 galanin. Staining for Ki-67, TUNEL and Masson-Fontana were used to analyse proliferation, apoptosis and hair cycle staging of the HFs. Functional effects of galanin were tested in serum-free HF organ culture. Results: Galanin-like immunoreactivity was detected in the outer root sheath (ORS) and inner root sheath. Additionally, galanin mRNA was detected in ORS keratinocytes and all HF samples tested. Galanin receptor transcripts (GalR2, GalR3) were also detected in selected samples. Galanin reduced proliferation of hair matrix keratinocytes in situ compared with vehicle-treated controls, shortened the hair growth phase (anagen) in vitro and reduced hair shaft elongation. This was accompanied by the premature development of a catagen-like morphology of galanin-treated HFs. Conclusions: We present the first evidence that human HFs are both a source and a functionally relevant target of galanin. Due to its hair growth-inhibitory properties in vitro, galanin application deserves further exploration as a potential new treatment strategy for unwanted hair growth (hirsutism, hypertrichosis).

AB - Background: Galanin is a trophic factor of the central and peripheral nervous system that shows widespread distribution in human skin. However, the exact localization and the role of galanin in the hair follicle (HF) remain to be clarified. Objectives: To characterize galanin expression in human scalp HFs and to examine the effects of galanin on normal human scalp HF growth in organ culture. Methods: Immunohistochemistry was performed on cryosections of human female scalp skin. Anagen HFs were microdissected and cultured up to 9 days and treated with 100 nmol L -1 galanin. Staining for Ki-67, TUNEL and Masson-Fontana were used to analyse proliferation, apoptosis and hair cycle staging of the HFs. Functional effects of galanin were tested in serum-free HF organ culture. Results: Galanin-like immunoreactivity was detected in the outer root sheath (ORS) and inner root sheath. Additionally, galanin mRNA was detected in ORS keratinocytes and all HF samples tested. Galanin receptor transcripts (GalR2, GalR3) were also detected in selected samples. Galanin reduced proliferation of hair matrix keratinocytes in situ compared with vehicle-treated controls, shortened the hair growth phase (anagen) in vitro and reduced hair shaft elongation. This was accompanied by the premature development of a catagen-like morphology of galanin-treated HFs. Conclusions: We present the first evidence that human HFs are both a source and a functionally relevant target of galanin. Due to its hair growth-inhibitory properties in vitro, galanin application deserves further exploration as a potential new treatment strategy for unwanted hair growth (hirsutism, hypertrichosis).

UR - http://www.scopus.com/inward/record.url?scp=84863333036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863333036&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2133.2012.10890.x

DO - 10.1111/j.1365-2133.2012.10890.x

M3 - Article

C2 - 22329353

AN - SCOPUS:84863333036

VL - 167

SP - 10

EP - 16

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 1

ER -